Variables | Unweighted characteristics (before IPTW) | Characteristics after weighting for IPTW | ||||||
---|---|---|---|---|---|---|---|---|
Apixaban (n = 4471) |
Dabigatran (n = 3246) |
Rivaroxaban (n = 3299) |
Warfarin (n = 10,338) |
Apixaban (n = 4471) |
Dabigatran (n = 3246) |
Rivaroxaban (n = 3299) |
Warfarin (n = 10,338) |
|
Medications, % | ||||||||
Beta-blocker | 65.3 | 64.6 | 63.8 | 72.9 | 69.7 | 69.3 | 68.4 | 69.0 |
ARB | 17.6 | 15.6 | 17.7 | 15.8 | 17.1 | 16.5 | 17.4 | 16.1 |
ACE inhibitor | 38.0 | 42.6 | 40.1 | 46.2 | 42.8 | 44.3 | 44.1 | 43.8 |
Calcium channel blocker | 15.2 | 17.2 | 15.8 | 16.5 | 17.1 | 15.8 | 15.1 | 16.7 |
Corticosteroid (oral) | 5.3 | 4.5 | 5.5 | 6.7 | 5.8 | 5.3 | 6.5 | 6.3 |
NSAID | 11.6 | 12.9 | 11.9 | 12.1 | 11.5 | 12.4 | 11.3 | 12.5 |
Statin | 62.4 | 60.6 | 59.7 | 65.2 | 64.3 | 63.1 | 63.4 | 63.7 |
SSRI/SNRI | 20.3 | 19.7 | 20.2 | 21.5 | 18.7 | 19.6 | 20.5 | 20.9 |
Antiarrhythmic | 18.7 | 19.9 | 19.4 | 16.7 | 18.4 | 18.1 | 18.0 | 18.2 |
Insulin | 24.7 | 20.3 | 22.7 | 27.7 | 28.9 | 25.3 | 24.9 | 25.5 |
Diuretic | 42.5 | 37.3 | 38.7 | 49.5 | 45.5 | 45.2 | 46.0 | 45.3 |
Opioid | 31.3 | 32.2 | 31.2 | 38.4 | 35.1 | 35.4 | 35.7 | 35.3 |